TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

被引：24

作者：

Bardia, Aditya

Hurvitz, Sara

Press, Michael F.

Wang, Lisa S.

McAndrew, Nicholas P.

Chan, David

Phan, Vu

Villa, Deborah

Tetef, Merry L.

Chamberlain, Erin

Abdulla, Nihal

Lomis, Thomas

Spring, Laura M.

Applebaum, Steven

Dakhil, Shaker

DiCarlo, Brian

Kim, David D.

Kirimis, Evangelia

Lawler, William E.

Master, Aashini K.

McCann, Kelly

Hayashi, Edwin

Kivork, Christine

Chauv, James

机构：

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS22-GS2-03

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

GS2-03

引用

页数：4